QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Doug Lakin who wrote (16)	6/4/1996 3:19:00 PM
From: Henry Niman	of 1321

Doug, Ligand uses hormone receptors to screen for analogues that act as agonists and antagonists. The primary focus is cancer and women's health, but they have strategic alliances with PFE (osteoporosis), GLX (atheroscleosis), AGN (retinoids for cancer and skin & eye disease), ABT (inflammation), AHP (women's health). SBE (hemopoetic growth factors), and Sankyo (inflammation). They have also in-linced products from CHIR and QLTIF for sale in Canada. You can get a good feel for the company by looking at prnewswire.com. Under Ligand company news you can find a years worth of press releases. Let me know if you have any specific questions. Henry N Fox Chapel

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next